These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18501865)

  • 1. Anxiety and depression screening for youth in a primary care population.
    Katon W; Russo J; Richardson L; McCauley E; Lozano P
    Ambul Pediatr; 2008; 8(3):182-8. PubMed ID: 18501865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital Anxiety and Depression Scale-Anxiety subscale (HADS-A) and The State-Trait Anxiety Inventory (STAI) accuracy for anxiety disorders detection in drug-resistant mesial temporal lobe epilepsy patients.
    Zingano BL; Guarnieri R; Diaz AP; Schwarzbold ML; Wolf P; Lin K; Walz R
    J Affect Disord; 2019 Mar; 246():452-457. PubMed ID: 30599368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease.
    Bernstein CN; Zhang L; Lix LM; Graff LA; Walker JR; Fisk JD; Patten SB; Hitchon CA; Bolton JM; Sareen J; El-Gabalawy R; Marriott J; Marrie RA;
    Inflamm Bowel Dis; 2018 Aug; 24(9):1867-1875. PubMed ID: 29668911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening efficiency of the Mood and Feelings Questionnaire (MFQ) and Short Mood and Feelings Questionnaire (SMFQ) in Swedish help seeking outpatients.
    Jarbin H; Ivarsson T; Andersson M; Bergman H; Skarphedinsson G
    PLoS One; 2020; 15(3):e0230623. PubMed ID: 32210463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of mental health care for youth with asthma and comorbid anxiety and depression.
    Katon WJ; Richardson L; Russo J; Lozano P; McCauley E
    Med Care; 2006 Dec; 44(12):1064-72. PubMed ID: 17122709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for anxiety and depression in primary care with the Duke Anxiety-Depression Scale.
    Parkerson GR; Broadhead WE
    Fam Med; 1997 Mar; 29(3):177-81. PubMed ID: 9085098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A validation study of the Four-Dimensional Symptom Questionnaire (4DSQ) in insurance medicine.
    Langerak W; Langeland W; van Balkom A; Draisma S; Terluin B; Draijer N
    Work; 2012; 43(3):369-80. PubMed ID: 22927600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Criterion validity of the Mood and Feelings Questionnaire for depressive episodes in clinic and non-clinic subjects.
    Daviss WB; Birmaher B; Melhem NA; Axelson DA; Michaels SM; Brent DA
    J Child Psychol Psychiatry; 2006 Sep; 47(9):927-34. PubMed ID: 16930387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and diagnostic validity of the M-3 checklist: a brief, self-rated screen for depressive, bipolar, anxiety, and post-traumatic stress disorders in primary care.
    Gaynes BN; DeVeaugh-Geiss J; Weir S; Gu H; MacPherson C; Schulberg HC; Culpepper L; Rubinow DR
    Ann Fam Med; 2010; 8(2):160-9. PubMed ID: 20212303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of the 12-item General Health Questionnaire (GHQ-12) in detecting depressive and anxiety disorders among high school students.
    Baksheev GN; Robinson J; Cosgrave EM; Baker K; Yung AR
    Psychiatry Res; 2011 May; 187(1-2):291-6. PubMed ID: 21067813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the best screening test for depression in chronic spinal pain patients?
    Choi Y; Mayer TG; Williams MJ; Gatchel RJ
    Spine J; 2014 Jul; 14(7):1175-82. PubMed ID: 24225008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of comorbid anxiety and depressive disorders on health care utilization and costs among adolescents with asthma.
    Richardson LP; Russo JE; Lozano P; McCauley E; Katon W
    Gen Hosp Psychiatry; 2008; 30(5):398-406. PubMed ID: 18774422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for depression in youth with epilepsy: Psychometric analysis of NDDI-E-Y and NDDI-E in a French population.
    Viellard M; Villeneuve N; Milh M; Lépine A; Micoulaud-Franchi JA; McGonigal A
    Epilepsy Behav; 2019 Sep; 98(Pt A):19-26. PubMed ID: 31299528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the psychometric properties of the Beck Depression Inventory-II, the Montgomery and Åsberg Depression Rating Scale, and the Hospital Anxiety and Depression Scale in a sample from a healthy population.
    Kjaergaard M; Arfwedson Wang CE; Waterloo K; Jorde R
    Scand J Psychol; 2014 Feb; 55(1):83-9. PubMed ID: 24256317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
    Mathet F; Martin-Guehl C; Maurice-Tison S; Bouvard MP
    Encephale; 2003; 29(5):391-400. PubMed ID: 14615688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Web-based screening instrument for depression and anxiety disorders in primary care.
    Farvolden P; McBride C; Bagby RM; Ravitz P
    J Med Internet Res; 2003; 5(3):e23. PubMed ID: 14517114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric properties of the Polish version of the Hamilton Anxiety Rating Scale in patients with epilepsy with and without comorbid anxiety disorder.
    Wiglusz MS; Landowski J; Cubała WJ
    Epilepsy Behav; 2019 May; 94():9-13. PubMed ID: 30884410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses.
    Löwe B; Spitzer RL; Gräfe K; Kroenke K; Quenter A; Zipfel S; Buchholz C; Witte S; Herzog W
    J Affect Disord; 2004 Feb; 78(2):131-40. PubMed ID: 14706723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety and depressive disorders are associated with smoking in adolescents with asthma.
    Bush T; Richardson L; Katon W; Russo J; Lozano P; McCauley E; Oliver M
    J Adolesc Health; 2007 May; 40(5):425-32. PubMed ID: 17448400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of the Depression, Anxiety and Stress Scale (DASS-21) for Screening on Comorbid Internalizing Disorders among Youth in Substance Use Disorder Treatment.
    Moska C; Goudriaan AE; Blanken P; Hendriks V
    Eur Addict Res; 2023; 29(6):385-393. PubMed ID: 37848011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.